Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$11.4M
2 rounds on record
Latest round
$11.4M
Venture round · Jan 2023 · 3 yr ago
Backers
1
Redalpine
The money's age
Long since its last round
44 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Funding rounds
RoundDateAmountInvestorsSource
Debt Financing Dec 2025 $700k — SEC Form D
Venture round Jan 2023 $11.4M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Genialis, Inc. sec
Founders and leadersfrom filings, registers and the company's site
Luka AusecExecutive OfficerSEC Form D
Rafael RosengartenExecutive Officer, DirectorSEC Form D
Miha StajdoharExecutive Officer, DirectorSEC Form D
Tjasa KutinExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Precision oncology, built for Latin America. Point-of-care software and a multimodal cancer atlas.
Blank BioSeed $7.2M · 4 mo ago
RNA intelligence for precision oncology. Blank Bio builds AI foundation models that help pharma teams identify the right patients for…
GenomateConvertible Note $2M · 18 mo ago • Founded 2022 • 51-200 employees
Genomate helps physicians find the right targeted therapy for every cancer patient based on the individual molecular profile of their…
CellplyVenture round $7.7M · 4 mo ago • 51-200 employees • 1 role
Cellply offers an automated platform for functional precision medicine.
About UsGET TO KNOWOur Founders The medical potential of AI and metabolite Dr. Leila Pirhajico-founderOn Beyond Genome: Opportunities and…
Sano GeneticsSeed $3.2M · 5 yr ago • Founded 2017
Sano’s end-to-end precision medicine platform de-risks trials, enabling clinical operations teams to move 10x faster and reduce cost by 5x.

Overview

Genialis is a precision oncology company helping the most promising molecules become life-saving medicines.

News

Blog 5 days ago
Genialis and Inventia Life Science Collaborate to Link Patient Biology with 3D Pancreatic Cancer Models
The collaboration pairs the Genialis Supermodel with Inventia Life Science's RASTRUM 3D cell model platform to test therapeutic hypotheses in models that mirror the tumor biology of specific patient groups Houston & Sydney - September 23, 2026, BusinessWi
Read more
Report
Podcast 11 days ago
The Kodak moment for drug discovery: AI, adaptation, and what stays human TPM podcast #61
Genialis SupermodelGenialis BioBridgeGenialis on LinkedInWelcome to Talking Precision Medicine (TPM podcast) - the podcast in which we discuss the future of healthcare and health technology, and how advances in data and data science are fueling the next i
Read more
Report
Podcast 1 month ago
What would you (and your AI) do with the world's largest curated chemistry data catalog? TPM podcast #60
Genialis Launches BioBridge to Help Derisk Global Drug Development of China-origin Oncology DrugsGenialis BioBridgeGenialis on LinkedInWelcome to Talking Precision Medicine (TPM podcast) - the podcast in which we discuss the future of healthcare and healt
Read more
Report
Blog 2 months ago
Genialis Supermodel White Paper
A technical guide to the Genialis SupermodelThe Genialis Supermodel is a foundation model of cancer biology that transforms RNA sequencing data into interpretable biomodule scores for biomarker discovery and therapeutic intelligence. This white paper prov
Read more
Report
Pro access
Upgrade to see all 14 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.

People

Luka Ausec
Executive Officer
Rafael Rosengarten
Executive Officer, Director
Miha Stajdohar
Executive Officer, Director
Tjasa Kutin
Executive Officer
Nadine Geiser
Director
Elia Stupka
Director
Ita Lu
Director
Hamzeh Abdul-Hadi
Director
Drew Volpe
Director
Cedric Odje
Director
Krista McKerracher
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Boston United States
HQ
68 Harrison Ave #605, PMB 29417, Boston, MA, 02111, US
company site

Financials

Total raised
$12.1M
Latest round
Debt Financing
Funding rounds
2
Funding rounds
Round Announced Amount
Debt Financing 2025 $700k Details
Venture - Series Unknown 2023 $11.4M Details